Skip to main content

Q/C Technologies, Inc.

QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001321834

No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Q/C Technologies, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of QCLS: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders23128+6
Shares4.88M70.9K5.80M+995.8K (+20.7%)
Value$30.7M$447.0K$41.8M+$11.5M (+38.0%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Q/C Technologies, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to QCLS in Q3 2021
InstitutionSharesValue% of portfolio
Mirae Asset Global Investments Co., Ltd.1,132,131$8.15M0.02%
Invesco Ltd.235,194$1.69M0.00%
Susquehanna International Group, LLP25,809$186.0K0.00%
Wolverine Trading, LLC15,553$112.0K0.00%
Bank of New York Mellon Corp11,717$84.0K0.00%
Tower Research Capital LLC (TRC)1,279$9.00K0.00%
Royal Bank of Canada930$7.00K0.00%
Toronto Dominion Bank90$1.00K0.00%

Sold out (2)

Institutions that held Q/C Technologies, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of QCLS in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
FNY Investment Advisers, LLC50,000$315.0K
Candriam Luxembourg S.C.A.18,073$114.0K

Not filed for Q3 2021 yet (1)

Institutions that held Q/C Technologies, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding QCLS in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
M Holdings Securities, Inc.70,909$447.0K